Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Brain Research

• Publication date

  2003-03-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-8993(02)04174-4PMID 12618347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum.

  2002cited by this paper
• Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.

  2002cited by this paper
• Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping.

  2002cited by this paper
• Interaction of cyclooxygenase-2 inhibitors and salicylate in gastric mucosal damage.

  2002cited by this paper
• Sodium salicylate enhances the expression of cyclooxygenase-2 in endotoxin-stimulated human mononuclear cells.

  2001cited by this paper
• Protective effect of histidine on para-nonylphenol-enhanced hydroxyl free radical generation induced by 1-methyl-4-phenylpyridinium ion (MPP+) in rat striatum.

  2001cited by this paper
• Selective Suppression of CCAAT/Enhancer-binding Protein β Binding and Cyclooxygenase-2 Promoter Activity by Sodium Salicylate in Quiescent Human Fibroblasts*

  2001cited by this paper
• Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.

  2001cited by this paper
• Inhibition of the cyclooxygenase isoenzymes COX‐1 and COX‐2 provide neuroprotection in the MPTP‐mouse model of Parkinson's disease

  2001cited by this paper
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cited by this paper
• Bupivacaine Hydrochloride Induces Muscle Fiber Necrosis and Hydroxyl Radical Formation-Dimethyl Sulphoxide Reduces Hydroxyl Radical Formation

  2001cited by this paper
• In vitro effects of NSAIDS and paracetamol on oxidative stress-related parameters of human erythrocytes.

  2001cited by this paper
• Microglia in neurodegeneration: Molecular aspects

  2001cited by this paper
• Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.

  2000cited by this paper
• In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

  2000cited by this paper
• Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages.

  2000cited by this paper
• Neurochemical Mechanisms Underlying Neuroprotective Actions of Bromocriptine, Salicylate, d- and L-Deprenyl in Neurodegeneration caused by MPTP

  2000cited by this paper
• Inhibitory effect of sodium salicylate on nitric oxide production from TM4 sertoli cells.

  2000cited by this paper
• Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells

  2000cited by this paper
• Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

  2000cited by this paper
• In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR)

  2000cited by this paper
• Neurotoxic Factors in Parkinson’s Disease and Related Disorders

  2000cited by this paper
• Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells.

  1999cited by this paper
• Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus.

  1999cited by this paper
• Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice

  1999cited by this paper
• Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.

  1999cited by this paper
• Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice

  1998cited by this paper
• Neuroprotection by bromocriptine against 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice1

  1998cited by this paper
• Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity.

  1998cited by this paper
• Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

  1998cited by this paper
• Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide.

  1998cited by this paper
• Hydroxyl radicals and nitric oxide in neurotoxicity and neuroprotection.

  1998cited by this paper
• Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol.

  1998cited by this paper
• Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol

  1998cited by this paper
• Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat.

  1997cited by this paper
• Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid.

  1997cited by this paper
• Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs.

  1997cited by this paper
• Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2.

  1997cited by this paper
• Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin*

  1997cited by this paper
• Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation

  1996cited by this paper
• Oxidative stress in neurodegenerative diseases.

  1996cited by this paper
• Elevated extracellular glutamate levels increased the formation of hydroxyl radical in the striatum of anesthetized rat.

  1995cited by this paper
• Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a β‐adrenergic agonist

  1994cited by this paper
• Ferrous‐Citrate Complex and Nigral Degeneration: Evidence for Free‐radical Formation and Lipid Peroxidation a

  1994cited by this paper
• Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a beta-adrenergic agonist.

  1994cited by this paper
• Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.

  1994cited by this paper
• Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.

  1994cited by this paper
• In Vivo Generation of Hydroxyl Radicals and MPTP‐Induced Dopaminergic Toxicity in the Basal Ganglia

  1994cited by this paper
• Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?

  1993cited by this paper
• Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model.

  1993cited by this paper
• Streptococcal M protein.

  1991cited by this paper
• Oxygen free radicals and Parkinson's disease.

  1991cited by this paper
• Inflammation and the mechanism of action of anti‐inflammatory drugs

  1987cited by this paper
• Modes of action of aspirin-like drugs.

  1985cited by this paper
• 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.

  2025cites this paper
• Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans

  2025cites this paper
• Association Between Upper Respiratory Tract Infections and Parkinson’s Disease in Korean Populations: A Nested Case–Control Study Using a National Health Screening Cohort

  2025cites this paper
• Zinc supplementation alleviates oxidative stress to inhibit chronic gastritis via the ROS/NF-κB pathway in a mouse model.

  2024cites this paper
• Peripheral Blood Immune Cells from Individuals with Parkinson’s Disease or Inflammatory Bowel Disease Share Deficits in Iron Storage and Transport that are Modulated by Non-Steroidal Anti-Inflammatory Drugs

  2024cites this paper
• A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects

  2023cites this paper
• Ternary diffusion in aqueous sodium salicylate + sodium dodecyl sulfate solutions

  2022cites this paper
• Inflammation and immune dysfunction in Parkinson disease

  2022cites this paper
• Biomarker of Neuroinflammation in Parkinson’s Disease

  2022influential citation
• Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats

  2019cites this paper
• Therapeutic Effect of Modulating TREM-1 via Anti-inflammation and Autophagy in Parkinson’s Disease

  2019cites this paper
• Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis

  2018cites this paper
• Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats

  2017influential citation
• Melatonin Attenuates Manganese and Lipopolysaccharide-Induced Inflammatory Activation of BV2 Microglia

  2017cites this paper
• Peripheral nerve and diclofenac sodium: Molecular and clinical approaches.

  2017cites this paper
• In vitro anti-neuroinflammatory and neuritogenic stimulatory effects of a medicinal mushroom lignosus rhinocerotis (Cooke) ryvarden / Syntyche Seow Ling Sing

  2016cites this paper
• Design of reprogrammed neuronal transplantation and nanobiomaterial-based microglial therapeutic technologies for management of Parkinson's disease

  2016cites this paper
• A computational study for the antioxidant capacity increases in hydroxy-derivatives of paracetamol and salicylic acid

  2015cites this paper
• Efeitos da exposição a um ambiente enriquecido sobre parâmetros comportamentais, bioquímicos e moleculares em um modelo murino da doença de Parkinson

  2015cites this paper
• A Structure and Antioxidant Activity Study of Paracetamol and Salicylic Acid

  2014cites this paper
• Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.

  2014cites this paper
• Does Melatonin Have a Protective Role against Side Effects of Nonsteroidal Anti-Inflammatory Drugs?

  2014cites this paper
• Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats.

  2014cites this paper
• Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).

  2013cites this paper
• Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells

  2013cites this paper
• Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.

  2013cites this paper
• EFEITO TIPO-ANTIDEPRESSIVO E ANTIOXIDANTE DO IBUPROFENO NO MODELO DA DOENÇA DE PARKINSON INDUZIDO POR ADMINISTRAÇÃO DE ROTENONA INTRAPERITONEAL EM RATOS

  2013influential citation
• Effects of Hominis placenta on LPS-induced cell toxicity in BV2 microglial cells.

  2013cites this paper
• Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson’s disease

  2013cites this paper
• Sodium salicylate protects against rotenone‐induced Parkinsonism in rats

  2013influential citation
• Toxicity of non-steroidal anti-inflammatory drugs: a review of melatonin and diclofenac sodium association.

  2012influential citation
• The role of microglia–lymphocyte interaction in PD neuropathology

  2012cites this paper
• Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum

  2012cites this paper
• Studies of Depression-Related States in Animal Models of Parkinsonism

  2012cites this paper
• Oxidative Stress and Microglial Cells in Parkinson's Disease

  2012cites this paper
• Cyclooxygenase-Independent Neuroprotective Effects of Aspirin Against Dopamine Quinone-Induced Neurotoxicity

  2012cites this paper
• NSAIDs in the treatment and/or prevention of neurological disorders

  2012cites this paper
• Pathology of Neurodegenerative Diseases

  2012cites this paper
• n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats.

  2012cites this paper
• Evaluation of Anti-Inflammatory, Analgesic and Antipyretic Effects of Azadrichcta indica Leaf Extract on Fever-Induced Albino Rats (Wistar)

  2012cites this paper
• Brain Damage - Bridging Between Basic Research and Clinics

  2012cites this paper
• A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP

  2012cites this paper
• Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence

  2011cites this paper
• Inflammatory Responses and Regulation in Parkinson’s Disease

  2011cites this paper
• Aspirin reduces the apoptotic effect of etoposide via Akt activation and up-regulation of p21(cip).

  2011cites this paper
• The Promise of Neuroprotective Agents in Parkinson’s Disease

  2011cites this paper
• Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

  2010cites this paper
• Antiparkinsonian Effects of Aqueous Methanolic Extract of Hyoscyamus niger Seeds Result From its Monoamine Oxidase Inhibitory and Hydroxyl Radical Scavenging Potency

  2010cites this paper
• Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy

  2010cites this paper
• MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain

  2010cites this paper
• Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression.

  2010cites this paper
• Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.

  2010cites this paper
• L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation.

  2010cites this paper
• Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.

  2010cites this paper
• Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

  2010cites this paper
• Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease.

  2010cites this paper
• Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease

  2010cites this paper
• The neurobiology of the substantia nigra pars compacta: from motor to sleep regulation.

  2009cites this paper
• Investigation of Neuroprotective Effects of Cyclooxygenase Inhibitors in the 6-Hydroxydopamine Induced Rat Parkinson Model Siklooksijenaz ‹nhibitörlerinin 6-Hidroksidopamin ile Oluflturulan Deneysel Parkinson Modelinde Nöroprotektif Etkilerinin Araflt›r›lmas›

  2009cites this paper
• Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model.

  2009cites this paper
• Melatonin inhibits 6‐hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

  2009cites this paper
• Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta.

  2009cites this paper
• Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice

  2008cites this paper
• Modulation of dopaminergic neurotransmission in rat striatum upon in vitro and in vivo diclofenac treatment

  2008cites this paper
• Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation

  2008cites this paper
• Cytokines in CNS Inflammation and Disease

  2008cites this paper
• In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.

  2008cites this paper
• DJ-1 , a Parkinson ’ s Disease-associated Gene , Prevent Excessive Glial Inflammatory Responses through Interaction with SHP-1 by

  2008cites this paper
• Will it ever become possible to prevent dopaminergic neuronal degeneration?

  2008cites this paper
• Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease.

  2008cites this paper
• Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease

  2008cites this paper
• Evidence for Hydroxyl Radical Scavenging Action of Nitric Oxide Donors in the Protection Against 1-Methyl-4-phenylpyridinium-induced Neurotoxicity in Rats

  2008cites this paper
• Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

  2007cites this paper
• Non-steroidal anti-inflammatory drugs in Parkinson's disease.

  2007cites this paper
• Death in the substantia nigra: a motor tragedy

  2007cites this paper
• Temporal mRNA profiles of inflammatory mediators in the murine MPTP model of Parkinson’s disease

  2007cites this paper
• Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action

  2007cites this paper
• Advances in the treatment of Parkinson's disease.

  2007cites this paper
• Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?

  2007cites this paper
• Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

  2007cites this paper
• Apoptotic Mode of Cell Death in Substantia Nigra Following Intranigral Infusion of the Parkinsonian Neurotoxin, MPP+ in Sprague-Dawley Rats: Cellular, Molecular and Ultrastructural Evidences

  2007cites this paper
• Inflammation as a causative factor in the aetiology of Parkinson's disease

  2007cites this paper
• Striatal and nigral COX-2 expression after chronic typical and atypical neuroleptic administration in rats.

  2007cites this paper
• Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease

  2006cites this paper
• The pathogenesis of cell death in Parkinson's disease

  2006cites this paper
• Aspirin reduces the outcome of anticancer therapy in Meth A–bearing mice through activation of AKT-glycogen synthase kinase signaling

  2006cites this paper
• Non-steroidal anti-inflammatory agents, tolmetin and sulindac, inhibit liver tryptophan 2,3-dioxygenase activity and alter brain neurotransmitter levels.

  2006cites this paper
• Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: Role of 5HT2A/C-receptors

  2006cites this paper
• Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study.

  2006cites this paper
• 7‐Nitroindazole Protects Striatal Dopaminergic Neurons against MPP+‐Induced Degeneration

  2006cites this paper
• Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state.

  2006cites this paper
• Non-steroidal anti-inflammatory agents, tolmetin and sulindac, attenuate oxidative stress in rat brain homogenate and reduce quinolinic acid-induced neurodegeneration in rat hippocampal neurons

  2006cites this paper
• Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.

  2006cites this paper
• L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.

  2006cites this paper
• Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease

  2006cites this paper
• ROLES OF CYCLOOXYGENASE-2 IN MICROGLIAL ACTIVATION AND DOPAMINERGIC CELL DEATH

  2006cites this paper
• Determination of nonsteroidal anti-inflammatory drugs in serum by microchip capillary electrophoresis with electrochemical detection

  2006cites this paper
• Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.

  2005cites this paper
• Mesenchymal Stem Cells Therapy in Progressive Rat Model of Parkinson ' s Disease

  2005cites this paper
• Cyclooxygenase-2 Is an Obligatory Factor in Methamphetamine-Induced Neurotoxicity

  2005cites this paper